Synthesis, in Vivo and in Silico Studies of N-Aryl-4-(1,3-Dioxoisoindolin-2-Yl)Benzamides as an Anticonvulsant Agent

Background: These days epilepsy is a common neurological disorder, which can affect on quality of life by unpredictable seizure. Thalidomide is one of the drugs to control the epilepsy but side effects such as teratogenicity, made it difficult to use. Methods: Six new analogues of N-aryl-4-(1,3-diox...

Full description

Saved in:
Bibliographic Details
Main Authors: Parisa Kiminejad Malaie (Author), Mehdi Asadi (Author), Faezeh Sadat Hosseini (Author), Mahmood Biglar (Author), Massoud Amanlou (Author)
Format: Book
Published: Tabriz University of Medical Sciences, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ccfe554a408546f5ae4f26e1243f6a93
042 |a dc 
100 1 0 |a Parisa Kiminejad Malaie  |e author 
700 1 0 |a Mehdi Asadi  |e author 
700 1 0 |a Faezeh Sadat Hosseini  |e author 
700 1 0 |a Mahmood Biglar  |e author 
700 1 0 |a Massoud Amanlou  |e author 
245 0 0 |a Synthesis, in Vivo and in Silico Studies of N-Aryl-4-(1,3-Dioxoisoindolin-2-Yl)Benzamides as an Anticonvulsant Agent 
260 |b Tabriz University of Medical Sciences,   |c 2020-03-01T00:00:00Z. 
500 |a 2383-2886 
500 |a 10.34172/PS.2019.54 
520 |a Background: These days epilepsy is a common neurological disorder, which can affect on quality of life by unpredictable seizure. Thalidomide is one of the drugs to control the epilepsy but side effects such as teratogenicity, made it difficult to use. Methods: Six new analogues of N-aryl-4-(1,3-dioxoisoindolin-2-yl)benzamides were synthesized and tested for anti-seizure activity. To evaluate the anti-seizure activity of these new derivatives, 40 mice in 8 groups were received 10 mg/Kg of each new derivatives 30 min before the injection of pentylenetetrazole (PTZ, 70 mg/kg) to induced seizures. Latency time to first symptom of seizure was measured and compared to vehicle and standard groups. Docking methodology was applied to study on mode of interaction between GABAA receptor and synthetized compounds.Results: Structures of the all synthesized compounds were confirmed by NMR and mass spectroscopy. The latency time and mortality rate were individually measured for an hour after injection of pentylenetetrazole. Docking study revealed that synthesized compounds and thalidomide interact in similar conformation with GABAA receptor.Conclusion: The experimental and docking results were found in good correlation and demonstrated that the most active compound (5a), with 3,4-dimethylphenyl residue increased the duration of seizure inhibition threshold in comparison with thalidomide. 
546 |a EN 
690 |a epilepsy 
690 |a molecular docking simulation 
690 |a phthalimide 
690 |a seizures 
690 |a thalidomide 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutical Sciences, Vol 26, Iss 1, Pp 38-44 (2020) 
787 0 |n https://ps.tbzmed.ac.ir/PDF/Pharm-32841 
787 0 |n https://doaj.org/toc/2383-2886 
856 4 1 |u https://doaj.org/article/ccfe554a408546f5ae4f26e1243f6a93  |z Connect to this object online.